Capital Research Global Investors Sells 629,557 Shares of Synopsys, Inc. $SNPS

Capital Research Global Investors lowered its stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 24.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,894,955 shares of the semiconductor company’s stock after selling 629,557 shares during the quarter. Capital Research Global Investors’ holdings in Synopsys were worth $890,105,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Thurston Springer Miller Herd & Titak Inc. bought a new position in Synopsys in the 4th quarter worth about $28,000. Oakworth Capital Inc. boosted its stake in Synopsys by 3,700.0% in the 4th quarter. Oakworth Capital Inc. now owns 76 shares of the semiconductor company’s stock worth $36,000 after purchasing an additional 74 shares during the period. KERR FINANCIAL PLANNING Corp bought a new position in Synopsys in the 3rd quarter worth about $38,000. N.E.W. Advisory Services LLC boosted its stake in Synopsys by 128.6% in the 4th quarter. N.E.W. Advisory Services LLC now owns 80 shares of the semiconductor company’s stock worth $38,000 after purchasing an additional 45 shares during the period. Finally, WealthCollab LLC boosted its stake in Synopsys by 110.8% in the 3rd quarter. WealthCollab LLC now owns 78 shares of the semiconductor company’s stock worth $38,000 after purchasing an additional 41 shares during the period. Institutional investors own 85.47% of the company’s stock.

Synopsys Price Performance

Shares of Synopsys stock opened at $464.85 on Monday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The business’s 50 day simple moving average is $466.55 and its two-hundred day simple moving average is $458.28. The stock has a market capitalization of $89.01 billion, a P/E ratio of 107.60, a price-to-earnings-growth ratio of 2.71 and a beta of 1.22. Synopsys, Inc. has a one year low of $376.18 and a one year high of $651.73.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business’s quarterly revenue was up 41.9% on a year-over-year basis. During the same period in the previous year, the firm earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Analysts forecast that Synopsys, Inc. will post 10.74 EPS for the current year.

Analyst Upgrades and Downgrades

SNPS has been the subject of several analyst reports. Rosenblatt Securities raised their target price on Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a research note on Tuesday, May 26th. BNP Paribas Exane lifted their price target on Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a research report on Thursday, May 28th. Stifel Nicolaus lifted their price target on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Morgan Stanley lifted their price target on Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a research report on Thursday, May 28th. Finally, Bank of America lifted their price target on Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Nine analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Synopsys has an average rating of “Hold” and a consensus target price of $563.81.

Check Out Our Latest Analysis on Synopsys

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.